{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:03:29Z","timestamp":1791169409072,"version":"4.1.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Belgian Foundation"},{"name":"Flemish Liga"},{"name":"Federal Public Service of Health"},{"name":"Children Cancer Fund Ghent"},{"name":"Australian National Health and Medical Research Council","award":["APP1047995"],"award-info":[{"award-number":["APP1047995"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.exphem.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,6,28]],"date-time":"2015-06-28T01:14:50Z","timestamp":1435454090000},"page":"625-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Novel biological insights in T-cell acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"43","author":[{"given":"Kaat","family":"Durinck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Peirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelynn","family":"Wallaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Van Loocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Matthijssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Rondou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Van Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Moerloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Speleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Poppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.05.017_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ni.1887","article-title":"Decision checkpoints in the thymus","volume":"11","author":"Carpenter","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2015.05.017_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.it.2014.03.001","article-title":"The chromatin landscape and transcription factors in T cell programming","volume":"35","author":"Rothenberg","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2015.05.017_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/bfgp\/elt027","article-title":"Epigenetic mechanisms and developmental choice hierarchies in T-lymphocyte development","volume":"12","author":"Rothenberg","year":"2013","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.exphem.2015.05.017_bib4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199411103311902","article-title":"Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission","volume":"331","author":"Barrett","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib5","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.017_bib6","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.05.017_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib9","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Van Vlierberghe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)","volume":"106","author":"Soulier","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jbior.2012.10.005","article-title":"IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia","volume":"53","author":"Ribeiro","year":"2013","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.exphem.2015.05.017_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymeth.2014.10.015","article-title":"Kinases, tails and more: regulation of PTEN function by phosphorylation","volume":"77\u201378","author":"Fragoso","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.exphem.2015.05.017_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbior.2014.05.005","article-title":"PTEN and leukemia stem cells","volume":"56","author":"Fragoso","year":"2014","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.exphem.2015.05.017_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2013.08.017","article-title":"The multiple layers of non-genetic regulation of PTEN tumour suppressor activity","volume":"50","author":"Correia","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2015.05.017_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.advenzreg.2011.09.019","article-title":"PI3K\/Akt\/mTORC1 and MEK\/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy","volume":"52","author":"Martelli","year":"2012","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.exphem.2015.05.017_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1590\/S0100-879X2008005000016","article-title":"Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications","volume":"41","author":"Cardoso","year":"2008","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbior.2014.04.004","article-title":"Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells","volume":"56","author":"Martelli","year":"2014","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.exphem.2015.05.017_bib18","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood.V84.12.4038.bloodjournal84124038","article-title":"Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias","volume":"84","author":"Hebert","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1101\/gad.415507","article-title":"The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells","volume":"21","author":"Bracken","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.017_bib21","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1182\/blood-2009-07-233346","article-title":"Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia","volume":"114","author":"Volanakis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.exphem.2012.11.006","article-title":"Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia","volume":"41","author":"Volanakis","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2015.05.017_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib24","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MOH.0000000000000058","article-title":"The clonal evolution of leukemic stem cells in T-cell acute lymphoblastic leukemia","volume":"21","author":"Tremblay","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2015.05.017_bib29","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1182378","article-title":"The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal","volume":"327","author":"McCormack","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.017_bib31","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2012-09-458570","article-title":"Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL","volume":"122","author":"McCormack","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib32","doi-asserted-by":"crossref","first-page":"e85883","DOI":"10.1371\/journal.pone.0085883","article-title":"LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2015.05.017_bib33","doi-asserted-by":"crossref","first-page":"e1004768","DOI":"10.1371\/journal.pgen.1004768","article-title":"SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells","volume":"10","author":"Gerby","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib34","doi-asserted-by":"crossref","first-page":"e1004881","DOI":"10.1371\/journal.pgen.1004881","article-title":"Controlling preleukemic thymocyte self-renewal","volume":"10","author":"Goossens","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/leu.2014.292","article-title":"Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice","volume":"29","author":"Shields","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib36","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2007.11.5253","article-title":"Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome","volume":"25","author":"Baldus","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.017_bib37","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","article-title":"Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia","volume":"28","author":"Gutierrez","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.017_bib38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gcc.22039","article-title":"The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL","volume":"52","author":"Grossmann","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2015.05.017_bib39","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1182\/blood-2013-08-521518","article-title":"SET-NUP214 is a recurrent gammadelta lineage-specific fusion transcript associated with corticosteroid\/chemotherapy resistance in adult T-ALL","volume":"123","author":"Ben Abdelali","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3324\/haematol.2013.086082","article-title":"The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest","volume":"98","author":"Ben Abdelali","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib41","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.017_bib42","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","article-title":"Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia","volume":"123","author":"Beldjord","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2015.05.017_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature09732","article-title":"SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction","volume":"471","author":"Inuzuka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.2011.08955.x","article-title":"Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15","volume":"156","author":"Inukai","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.017_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.017_bib47","doi-asserted-by":"crossref","unstructured":"Wood BL, Asselin B, Raetz EA. T-Lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in Children's Oncology Group (COG) Study AALL0434. Paper presented at 56th ASH Annual Meeting and Exposition; December, 2014; San Francisco, CA, USA.","DOI":"10.1182\/blood.V124.21.1.1"},{"key":"10.1016\/j.exphem.2015.05.017_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.05.017_bib49","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/cdd.2014.44","article-title":"Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression","volume":"21","author":"Denecker","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2015.05.017_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","article-title":"The ZEB\/miR-200 feedback loop\u2013a motor of cellular plasticity in development and cancer?","volume":"11","author":"Brabletz","year":"2010","journal-title":"EMBO Rep"},{"key":"10.1016\/j.exphem.2015.05.017_bib51","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64464-1","article-title":"Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer","volume":"161","author":"Rosivatz","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2015.05.017_bib52","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1182\/blood-2010-08-300236","article-title":"The EMT regulator Zeb2\/Sip1 is essential for murine embryonic hematopoietic stem\/progenitor cell differentiation and mobilization","volume":"117","author":"Goossens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib53","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1038\/ncomms6794","article-title":"ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling","volume":"6","author":"Goossens","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2015.05.017_bib54","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.leu.2402249","article-title":"A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib55","first-page":"5329","article-title":"The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2)","volume":"63","author":"Nagel","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib56","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.2246","article-title":"The TLX1 oncogene drives aneuploidy in T cell transformation","volume":"16","author":"De Keersmaecker","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib57","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia","volume":"118","author":"Gutierrez","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib58","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.05.017_bib59","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","article-title":"The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion","volume":"7","author":"Comijn","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib60","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1084\/jem.20122727","article-title":"Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential","volume":"211","author":"Treanor","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib61","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/blood-2014-04-566687","article-title":"JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model","volume":"124","author":"Degryse","year":"2014","journal-title":"Blood"},{"issue":"Spec No 1","key":"10.1016\/j.exphem.2015.05.017_bib62","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1093\/hmg\/ddi101","article-title":"Small regulatory RNAs in mammals","volume":"14","author":"Mattick","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.05.017_bib64","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yexcr.2014.08.033","article-title":"MicroRNAs in hematopoiesis","volume":"329","author":"Lazare","year":"2014","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng.858","article-title":"A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)","volume":"43","author":"Mavrakis","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10428190802626632","article-title":"Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia","volume":"50","author":"Nagel","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2015.05.017_bib67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ncb2037","article-title":"Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia","volume":"12","author":"Mavrakis","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.017_bib68","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.leukres.2012.02.013","article-title":"Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL","volume":"36","author":"Gusscott","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib69","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/leu.2014.133","article-title":"Notch and NF-kB signaling pathways regulate miR-223\/FBXW7 axis in T-cell acute lymphoblastic leukemia","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib70","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.20122516","article-title":"The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia","volume":"210","author":"Mansour","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib71","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3324\/haematol.2013.099515","article-title":"MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia","volume":"99","author":"Mets","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib72","doi-asserted-by":"crossref","first-page":"ra111","DOI":"10.1126\/scisignal.2005500","article-title":"Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia","volume":"7","author":"Sanghvi","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.exphem.2015.05.017_bib73","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/leu.2014.276","article-title":"MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia","volume":"29","author":"Mets","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nature10887","article-title":"Modular regulatory principles of large non-coding RNAs","volume":"482","author":"Guttman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nsmb.2942","article-title":"Discovery and annotation of long noncoding RNAs","volume":"22","author":"Mattick","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2015.05.017_bib76","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cell.2014.05.049","article-title":"Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia","volume":"158","author":"Trimarchi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib78","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3324\/haematol.2014.115683","article-title":"The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia","volume":"99","author":"Durinck","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib80","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1093\/nar\/gkt826","article-title":"Predicting enhancer transcription and activity from chromatin modifications","volume":"41","author":"Zhu","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib81","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1259418","article-title":"Gene regulation. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells","volume":"347","author":"Arner","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.017_bib82","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","article-title":"A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping","volume":"159","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib83","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib84","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib85","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature14154","article-title":"Super-enhancers delineate disease-associated regulatory nodes in T cells","volume":"520","author":"Vahedi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib86","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element","volume":"346","author":"Mansour","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.017_bib87","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1038\/ncomms7094","article-title":"Site- and allele-specific polycomb dysregulation in T-cell leukaemia","volume":"6","author":"Navarro","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2015.05.017_bib88","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1073\/pnas.1315023111","article-title":"NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.017_bib89","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib90","doi-asserted-by":"crossref","first-page":"E4946","DOI":"10.1073\/pnas.1407079111","article-title":"Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia","volume":"111","author":"Yashiro-Ohtani","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.017_bib91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia","volume":"45","author":"De Keersmaecker","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib93","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature13605","article-title":"Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia","volume":"514","author":"Ntziachristos","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","article-title":"The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia","volume":"125","author":"Van der Meulen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.15252\/embr.201439949","article-title":"Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure","volume":"16","author":"Pagliarini","year":"2015","journal-title":"EMBO Rep"},{"key":"10.1016\/j.exphem.2015.05.017_bib96","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib97","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s10495-014-1029-5","article-title":"Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner","volume":"19","author":"Yoon","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.exphem.2015.05.017_bib98","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1158\/1535-7163.MCT-11-0938","article-title":"Preclinical analysis of the gamma-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia","volume":"11","author":"Samon","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2015.05.017_bib99","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature08543","article-title":"Direct inhibition of the NOTCH transcription factor complex","volume":"462","author":"Moellering","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib100","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib101","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.20110121","article-title":"High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling","volume":"208","author":"Medyouf","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib102","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ccr.2013.01.015","article-title":"Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer","volume":"23","author":"Roti","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib103","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2015.05.017_bib104","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1128\/MCB.24.14.6501-6513.2004","article-title":"Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members","volume":"24","author":"Jiang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.017_bib105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng.924","article-title":"Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia","volume":"43","author":"Zenatti","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib106","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Shochat","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib107","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20072182","article-title":"Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia","volume":"205","author":"Flex","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib108","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.017_bib109","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2012.064659","article-title":"Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish","volume":"97","author":"Onnebo","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ng.587","article-title":"Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia","volume":"42","author":"Kleppe","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.017_bib111","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","article-title":"PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia","volume":"117","author":"Kleppe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib112","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20081922","article-title":"CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia","volume":"206","author":"Gonzalez-Garcia","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib113","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1158\/1078-0432.CCR-13-0279","article-title":"Molecular pathways: molecular basis for sensitivity and resistance to JAK kinase inhibitors","volume":"20","author":"Meyer","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib114","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/leu.2014.282","article-title":"Ruxolitinib and survival improvement in patients with myelofibrosis","volume":"29","author":"Passamonti","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib115","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib116","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.exphem.2015.05.017_bib117","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib118","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","article-title":"Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199","volume":"4","author":"Chonghaile","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2015.05.017_bib119","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/leu.2013.377","article-title":"BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines","volume":"28","author":"Anderson","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib121","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.05.017_bib122","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib123","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3324\/haematol.2011.059030","article-title":"The significance of PTEN and Akt aberrations in pediatric T-cell acute lymphoblastic leukemia","volume":"97","author":"Zuurbier","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib124","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","article-title":"High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-Akt pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response","volume":"114","author":"Remke","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and Akt abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib126","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1084\/jem.20040789","article-title":"Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells","volume":"200","author":"Barata","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib127","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.4049\/jimmunol.180.12.8109","article-title":"IL-7 activates the phosphatidylinositol 3-kinase\/Akt pathway in normal human thymocytes but not normal human B cell precursors","volume":"180","author":"Johnson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2015.05.017_bib128","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V86.2.666.bloodjournal862666","article-title":"Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study","volume":"86","author":"Bash","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"Yilmaz","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib130","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention","volume":"441","author":"Zhang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccr.2014.01.032","article-title":"Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt\/mTORC1 pathway activation","volume":"25","author":"Blackburn","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib132","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2005-03-0929","article-title":"Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells","volume":"106","author":"Avellino","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib133","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib134","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","article-title":"mTOR and cancer therapy","volume":"25","author":"Easton","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.017_bib135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma","volume":"9","author":"Fan","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib136","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/0008-5472.CAN-08-4884","article-title":"Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia","volume":"69","author":"Chiarini","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib137","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/mol.108.047639","article-title":"Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl.oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia","volume":"74","author":"Fala","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.exphem.2015.05.017_bib138","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2012.02.029","article-title":"Targeting nonclassical oncogenes for therapy in T-ALL","volume":"21","author":"Subramaniam","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib139","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1158\/0008-5472.CAN-09-0301","article-title":"The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity","volume":"69","author":"Ali","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.017_bib140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib141","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","article-title":"CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer","volume":"159","author":"Chipumuro","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib142","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ccell.2014.10.019","article-title":"Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor","volume":"26","author":"Christensen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.017_bib143","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.017_bib144","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/onc.2014.290","article-title":"Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia","volume":"34","author":"Schwarzer","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.017_bib145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3324\/haematol.2014.118562","article-title":"T-ALL: ALL a matter of translation?","volume":"100","author":"Girardi","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.017_bib146","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1182\/blood-2010-06-292300","article-title":"Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance","volume":"116","author":"Chiu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib147","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1182\/blood-2012-08-448852","article-title":"Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia","volume":"121","author":"Diamanti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib148","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood-2006-06-030445","article-title":"Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia","volume":"109","author":"Cox","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.017_bib149","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/leu.2011.93","article-title":"Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations","volume":"25","author":"Gerby","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.017_bib150","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.20110105","article-title":"Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse","volume":"208","author":"Clappier","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib151","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/MCB.26.1.209-220.2006","article-title":"Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice","volume":"26","author":"Dumortier","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.017_bib152","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3078","article-title":"Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL","volume":"19","author":"Tzoneva","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.05.017_bib153","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ng.2558","article-title":"Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia","volume":"45","author":"Meyer","year":"2013","journal-title":"Nat Genet"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:08:03Z","timestamp":1654924083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":153,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0301472X15002118"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.017","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel biological insights in T-cell acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}